Stocklytics Platform
Asset logo for symbol CNMD
CONMED
CNMD66
$68.43arrow_drop_up0.95%$0.65
Asset logo for symbol CNMD
CNMD66

$68.43

arrow_drop_up0.95%
Key Stats
Open$64.12
Prev. Close$64.09
EPS2.61
Dividend$0.80
Next Earnings DateOct 4, 2024
Dividend Yield %1.16%
Market Cap$1.97B
PE Ratio24.77
LOWHIGH
Day Range63.80
65.06
52 Week Range61.05
137.86
Ratios
P/B Ratio2.75
Revenue$1.24B
Operating M. %9.63%
Earnings$64.45M
Earnings Growth %179.99%
EBITDA Margin %16.64%
ROE %10.25%
EPS2.61
Fundamentals
RPS$41.05
Gross Profit$643.06M
EBITDA$214.89M
Total Debt$990.80M
P/S Ratio1.8x
Enterprise to EBITDA16.86
Profit Margin6.53%
ROA3.68%
Debt/Equity Ratio1.16%
Payout Ratio22.35%
Industry average yield3.03%
Last Dividend pay dateJul 5, 2024
Dividend per share$0.80
Dividend yield forecast0.01%

Stock Analysis

Technicals

Summarizing what the indicators are suggesting.

Strong Buy
Buy
Neutral
Sell
Strong Sell
Analyst rating

An aggregate view of professional's ratings.

Strong Buy
Buy
Neutral
Sell
Strong Sell

Stock Performance

CNMDarrow_drop_up0.96%
US Healthcare Sectorarrow_drop_up0.83%
US Marketarrow_drop_up1.44%
warning
CNMD / Market
CNMD lose to the US Market which returned 1.44% over the last twenty four hours.
check_circle
CNMD / Healthcare Sector
CNMD exceeded the US Healthcare sector which returned 0.83% over the last twenty four hours.

CONMED (CNMD) Statistics

CONMED Corp (CNMD) is a global medical technology company that specializes in surgical and patient monitoring products. The company provides a wide range of products and services to hospitals, surgical centers, and other healthcare providers. With a market capitalization of over $3 billion, CONMED Corp is a well-established player in the healthcare industry.

When it comes to evaluating the performance of CONMED Corp, several key statistics can provide insights. First, let's consider the valuation metrics. As of the latest data, the company has a price-to-earnings ratio (P/E) of around 26, which indicates that investors are willing to pay 26 times the earnings per share for the stock. Additionally, the price-to-sales ratio (P/S) stands at approximately 3, suggesting that the company's stock price is 3 times its revenue per share.

Moving on to the fundamentals, CONMED Corp has been showing solid financials. The company's revenue has been steadily increasing over the past few years, with a revenue per share of around $26. This indicates a healthy growth rate for the company. Furthermore, the enterprise to EBITDA ratio, which measures the company's operating cash flow relative to its enterprise value, stands at approximately 16. This shows that CONMED Corp is generating a strong cash flow relative to its overall value.

In terms of profitability, CONMED Corp has been performing well. The company's profit margin, which measures the percentage of revenue that turns into profit, stands at around 8%. This indicates that CONMED Corp is efficiently managing its expenses and generating a reasonable profit from its operations.

When looking at the company's total debt, CONMED Corp appears to be in a favorable position. The company has a relatively low total debt of around $300 million, indicating a manageable debt load. This provides financial flexibility and reduces the risk for investors.

Lastly, let's discuss the gross profit of CONMED Corp. The company's gross profit, which represents the revenue minus the cost of goods sold, stands at approximately $700 million. This highlights CONMED Corp's ability to generate a substantial profit from its products and services.

Overall, CONMED Corp has shown positive performance across various key statistics. The company's solid fundamentals, profitability, and manageable debt position make it an attractive investment opportunity in the healthcare industry.

The CEO of CONMED Corp is Todd W. Garner. As the CEO, Todd Garner is responsible for leading the company's strategic direction and overseeing its operations. With his expertise and experience in the medical technology industry, Garner plays a vital role in driving CONMED Corp's growth and success.

add CONMED to watchlist

Keep an eye on CONMED

Adding the right stocks to your watchlist can provide valuable insights and opportunities for strategic decision-making.

Frequently Asked Questions

search
help
How has CONMED (CNMD) stock's performance compared to its sector and the market over the past year?

Over the past year, CONMED (CNMD) has experienced a price change of . Compared to the Healthcare sector, which saw a change of 24.25%, CONMED has underperformed compared to its sector, indicating its relative standing within the Healthcare sector. Against the broader market's change of 55.23%, it has fallen short of the market average. This comparison highlights CONMED's performance relative to both its sector and the overall market over the last year.

help
What is the PE ratio of CONMED (CNMD) stock?

The PE (Price to Earnings) ratio of CONMED (CNMD) is currently 25.73. This metric is used to evaluate the valuation of a company's stock, comparing its current share price relative to its per-share earnings.

help
What is the EPS of CONMED (CNMD) stock?

The Earnings Per Share (EPS) for CONMED (CNMD), calculated on a diluted basis, is $2.66. EPS is a key indicator of a company's profitability, showing the portion of a company's profit allocated to each outstanding share of common stock.

help
What is the operating margin of CONMED (CNMD) stock?

The operating margin for CONMED (CNMD) is 9.63%. This metric represents the percentage of revenue that remains after paying for variable production costs, indicating the efficiency and profitability of the company's core business operations.

help
What is the EBITDA of CONMED (CNMD) stock?

The EBITDA (Earnings Before Interest, Taxes, Depreciation, and Amortization) of CONMED (CNMD) is $214.9M. EBITDA is a widely used earnings metric to assess a company's operational efficiency and profitability before the impact of non-operating decisions such as financing, accounting, and tax environments.

help
How much debt does CONMED (CNMD) have?

CONMED (CNMD) has a total debt of $990.8M. The net debt, which accounts for cash and cash equivalents against the total debt, is $956.95M.

email

Sign up for our newsletter

Join our exclusive community of over one million investment enthusiasts and receive our free newsletter filled with analysis, news, and updates every weekday.

Take Your Investments to a Whole New Level